Minutes

MedTech Task Force

The Corporation of the City of Brampton

-
Boardroom CH-4A - 4th Floor, City Hall
Members Present:
  • Deputy Mayor H. Singh (Chair)
  • Dr. Mohamed Lachemi, President, Toronto Metropolitan University (Vice-Chair)
  • Regional Councillor M. Palleschi - Wards 2 and 6
  • Regional Councillor R. Santos - Wards 1 and 5
  • Regional Councillor G. Toor - Wards 9 and 10
  • Dave Casimiro, Managing Director, NorthWest Healthcare Properties REIT
  • Tony Chahine, CEO, Myant Inc.
  • Vito Ciciretto, President and CEO, Dynacare
  • Sheri Dodd, President, Medtronic Canada
  • Anton Katipunan, Development with RioCan, RioCan
  • Dr. Frank Martino, President & CEO, William Osler Health Systems
  • Dr. Dante Morra, Chief of Medical Staff, Trillium Health Partners
  • Dr. Janet Morrison, President & Vice Chancellor, Sheridan College
  • Carl Rodrigues, CEO, SOTI
  • Ken Spears, General Manager / Vice-President, Boston Scientific Canada
  • Darren Steedman, Vice-President, DG Group
  • Jay Stevens, CEO, The Stevens Company
  • Amy Swanson, Vice-President, MedTech Canada
  • Andreas Wegner, General Manager, Taro Pharmaceuticals 
  • Mahes Wickramasinghe, EVP & Chief Administrative Officer, Rogers
  • David Wyatt, Senior Vice President, Morguard Investments Ltd
Staff Present:
  • Patrick Brown, Mayor
  • Marlon Kallideen, Chief Administrative Officer
  • Steve Ganesh, Commissioner, Planning, Building and Growth Management
  • Clare Barnett, Director, Economic Development
  • Paul Aldunate, Expeditor, Office of the CAO
  • Martin Bohl, Sector manager, Health and Life Sciences, Office of the Chief Administrative Officer
  • Peter Fay, City Clerk
  • Tammi Jackson, Legislative Coordinator

The meeting was called to order at 6:00 p.m. and adjourned at 7:22 p.m.

As this meeting of the MedTech Task Force was conducted with electronic participation by Members of the Committee, the meeting started with the City Clerk calling the roll for attendance at the meeting, as follows:

Members present during roll call: Deputy Mayor Singh (Chair); Dr. Mohamed Lachemi, Toronto Metropolitan University, (Vice-Chair); Regional Councillor Santos, Regional Councillor Toor; Dave Casimiro, Managing Director, Northwest Healthcare Properties REIT; Vito Ciciretto, President and CEO, Dynacare; Sheri Dodd, President, Medtronic Canada; Anton Katipunan, Development with RioCan; Dr. Frank Marino, President and CEO, William Osler health Systems; Dr. Dante Morra, Chief of Medical Staff, Trillium Health Partners; Dr. Janet Morrison, President and Vice Chancellor, Sheridan College; Ken Spears, General manager / Vice-President, Boston Scientific Canada; Darren Steedman, Vice-President, DG Group; Jay Stevens, CEO, The Stevens Company; Amy Swanson, Vice-President, MedTech Canada; Andreas Wegner, General Manager, Taro Pharmaceuticals; Mahes Wickramasinghe, EVP and Chief Administrative Officer, Rogers; David Wyatt, Senior Vice-President, Morguard Investments Ltd.

Members absent during roll call:  Regional Councillor Palleschi; Tony Chahine, CEO, Myant Inc.; Carl Rodrigues, CEO, SOTI

Introductory and welcoming remarks were provided by Chair Singh, Mayor Brown and CAO Kallideen

The following motion was considered. 

  • MTTF001-2023

    That the agenda for the MedTech Task Force Committee Meeting of May 24, 2023, be approved as published and circulated.

    Carried

Martin Bohl, Sector Manager, Health and Life Science, Office of the Chief Administrative Officer, provided an overview of Economic Development partnerships developed with leading companies within the health and life sciences industry. Mr. Bohl identified that a Wet Labs project would be an opportunity for the Committee to work with the community on an action plan as there is a real need within the industry. 

The following motion was considered.

  • MTTF002-2023

    That the presentation from Martin Bohl, Sector Manager, Health and Life Science, Office of the Chief Administrative Officer, re: Economic Development, to the MedTech Task Force Committee Meeting of May 24, 2023, be received. 

    Carried

Dr. Mohamed Lachemi, President, Toronto Metropolitan University (TMU), provided a detailed overview on the subject matter that included: 

  • The 5 Pillars the School of Medicine will be designed around
  • Phases of Development.
  • Collaboration and Community Engagement.
  • Key Features and Differentiators of TMU’s Medical Education.
  • EDI Strategy and Action Plan.
  • Undergraduate Medical Education (UGME).
  • Proposal for the TMU Integrated Health Centres (IHCs).
  • Opportunities for Partnership.

Adam Kassam, Toronto Metropolitan University (TMU), provided further details on the subject matter that included: 

  • Institute for Health Innovation and Equity - 3 key elements ( Diversity Research and Policy, Health Technology, Digital Care & Prescriptive Medicine, Health Accelerator/Incubator).
  • Office of Help Innovation and Strategy.
  • Proposal for the TMU Integrated Health Centres (IHCs).
  • Integrated Health Centres - Community focal point.
  • The following motion was considered.

Glenn Craney, Toronto Metropolitan University (TMU), provided details on the subject matter with respect to the economic impact that included: 

  • The medical school will generate $1.2 - $2.6 B in economic activity over the next decade.
  • It will create over 7,000 direct and indirect jobs in the City of Brampton.
  • A Health Innovative District will attract new health related investment in Brampton. 

The following motion was considered.

  • MTTF003-2023

    That the presentation from Mohamed Lachemi, President, Toronto Metropolitan University, re: Toronto Metropolitan University's School of Medicine, to the MedTech Task Force Committee Meeting of May 24, 2023, be received. 

    Carried

Item 5.4 was brought forward and dealt with at this time.  

Steve Ganesh, Commissioner, Planning, Building and Growth Management provided an overview of the subject matter The City of Brampton Official Plan & City Lands Project and answered questions of clarification. 

Committee discussion on this matter included the following:

  • Advised that the City of Brampton is moving forward with several redeveloped lands to include MedTech Task Force initiatives. 
  • Clarified that the concept of City lands was established through the 2040 vision in 2018. 
  • Outlined the intention of the development framework is to develop a transit oriented community to piggy backs on the highways near by. 
  • Intent is the integration of mix of uses into the communities for the purpose of blending in the MedTech field.
  • The City of Mississauga partnered with the University of Toronto Campus as a joint effort in building a wet lab and dry lab space. 

The following motion was considered. 

  • MTTF004-2023

    That the presentation from Steve Ganesh, Commissioner, Planning, Building and Growth Management, re: Official Plan: Discussion and Consultation and City Lands: Highlighting MedTech Uses, to the MedTech Task Force Committee Meeting of May 24, 2023, be received. 

    Carried

Dealt with under Item 5.3 - Recommendation MTTF004-2023

Discussion included possible future agenda items including a presentation regarding Sheridan’s Nursing School, a MedTech Canada presentation and scheduled MedTech conference in Toronto next year.

The following motion was considered. 

  • MTTF005-2023

    That the MedTech Task Force Committee do now adjourn.

    Carried